Trisalus Life Sciences

IPO

Home – Developing Treatments for Liver & Pancreatic Tumors

Public · Westminster, United States · Founded 2013 · $91.5M raised

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$91.5M
Last Round
$12.8M Series DApr 2025
Rounds
5
Type
Public

About

TriSalus Life Sciences develops and commercializes drug delivery technology for patients with liver and pancreatic tumors. Its Pressure-Enabled Drug Delivery (PEDD) approach modulates pressure and flow to improve therapy penetration and overcome intravascular barriers, and has been used in more than 18,000 procedures. The company also studies combining immunomodulation therapy with proprietary intravascular regional delivery across multiple clinical trials.

Summary

Trisalus Life Sciences is a Healthcare company based in Westminster, United States, founded in 2013. It has raised $91.5M in total across 5 rounds, most recently a $12.8M Series D round in Apr 2025. Investors include Nantahala Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Private EquityPrivate EquityApr 2025
$22.0M

Sign up to see all 6 rounds

Series D through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trisalus Life Sciences on Indexed.vc
<a href="https://indexed.vc/companies/trisalus-life-sciences"><img src="https://indexed.vc/api/badge/company/trisalus-life-sciences" alt="Trisalus Life Sciences on Indexed.vc" width="260" height="76" /></a>